Belgium makes biomedical sector pay for overspending
This article was originally published in Clinica
Clinical analyses and imaging are among the sectors listed as being responsible for the Belgian healthcare 2001 budget deficit. Spending on clinical analyses totalled BFr 2,705.6 million ($61.6 million), and on medical imaging, BFr 2,656.8 million. The two sectors will now have to redress this balance and suffer a cut in the amount the health insurance paid per procedure for 12 months, beginning on July 1 2002.
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.